Accumulating evidence has revealed that MALAT1 enhances the expression of serine arginine-rich splicing factor 1 (SRSF1) and activates the mammalian target of rapamycin (mTOR) signaling pathway in hepatocellular carcinoma (HCC). This evidence concerns the gene MTOR and hepatocellular carcinoma.